Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer
- PMID: 6331882
Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer
Abstract
Twenty-six patients with metastatic colorectal adenocarcinoma were entered into a Phase I-II study of 5-fluorouracil (5-FUra)-high-dose leucovorin (CF). The starting dose of 5-FUra was 300 mg/sq m with escalation to 750 mg/sq m/week in 6 doses given by rapid i.v. injection midway during a 2-hr infusion of CF, 500 mg/sq m. Partial responses were seen in 9 of 23 patients (6 of 12 who had had previous 5-FUra). Complete normalization of liver enzymes was seen in two of these patients. Side effects were seen sporadically with 5-FUra doses up to 600 mg/sq m. At a 600-mg/sq m 5-FUra dose, 8 of 18 patients had diarrhea, and 2 of 18 had white blood cell counts less than 3000/microliter. At a 750-mg/sq m dose of 5-FUra, 6 of 11 patients had severe diarrhea and 6 of 11 had white blood cell counts less than 3000/microliter. Other toxicities were mild conjunctivitis and lacrimation, thinning of the nails, and alopecia. In bioavailability studies of CF p.o., no plasma CF could be detected. After CF i.v., mean plasma peak was 111.3 +/- 40.3 (S.D.) microM. 5-FUra-CF appears to be effective in patients clinically resistant to 5-FUra. This study is being extended to randomized trial of 5-FUra-CF versus 5-FUra alone.
Similar articles
-
Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.Clin Cancer Res. 2002 Aug;8(8):2488-98. Clin Cancer Res. 2002. PMID: 12171874 Clinical Trial.
-
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.Clin Cancer Res. 1995 Sep;1(9):955-60. Clin Cancer Res. 1995. PMID: 9816066 Clinical Trial.
-
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.Anticancer Res. 1997 Sep-Oct;17(5B):3867-71. Anticancer Res. 1997. PMID: 9427794 Clinical Trial.
-
Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.Cancer Clin Trials. 1981 Fall;4(3):281-3. Cancer Clin Trials. 1981. PMID: 6974612
-
Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.J Clin Oncol. 1990 Mar;8(3):491-501. doi: 10.1200/JCO.1990.8.3.491. J Clin Oncol. 1990. PMID: 2407810 Clinical Trial.
Cited by
-
Machine learning based prediction of recurrence after curative resection for rectal cancer.PLoS One. 2023 Dec 15;18(12):e0290141. doi: 10.1371/journal.pone.0290141. eCollection 2023. PLoS One. 2023. PMID: 38100485 Free PMC article.
-
Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells.BMC Cancer. 2022 Apr 4;22(1):363. doi: 10.1186/s12885-022-09417-3. BMC Cancer. 2022. PMID: 35379199 Free PMC article.
-
Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.World J Gastroenterol. 2016 Jan 14;22(2):490-500. doi: 10.3748/wjg.v22.i2.490. World J Gastroenterol. 2016. PMID: 26811602 Free PMC article. Review.
-
A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study.Cancer Chemother Pharmacol. 2015 Jan;75(1):37-47. doi: 10.1007/s00280-014-2611-9. Epub 2014 Oct 24. Cancer Chemother Pharmacol. 2015. PMID: 25342290 Free PMC article. Clinical Trial.
-
Colorectal carcinoma in first decade of life: our experience.Pediatr Surg Int. 2014 Aug;30(8):847-51. doi: 10.1007/s00383-014-3537-3. Epub 2014 Jul 9. Pediatr Surg Int. 2014. PMID: 25005910
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical